Christopher Hourigan received his medical degree and D. Phil. in Human Immunology from Oxford University. After residency training in medicine at Guy’s and St. Thomas’ Hospital in London and the Johns Hopkins Bayview Medical Center in Baltimore, he joined the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, where he was both a clinical fellow in medical oncology and a postdoctoral research fellow in the Immunology and Immunotherapy research program. He is ABIM board certified in Internal Medicine, Hematology and Medical Oncology.
Dr Hourigan came to the NHLBI in 2012. The Hourigan lab focuses on developing tools for the high sensitivity detection of residual acute myeloid leukemia (AML) after treatment, as well as the detection and monitoring of specific leukemia immune responses, and translate insights from the laboratory back to the clinic.